4Life® Transfer Factor™

4Life Transfer Factor® Products Included in 2013 Physicians’ Desk Reference

Salt Lake City, Utah (January 8, 2013) 4Life executives are pleased to announce that 4Life Transfer Factor® products are listed in the 2013 Physician’s Desk Reference (PDR).

“We are thrilled to be part of this prestigious and valuable publication. This is the ninth year that 4Life products have been listed,” stated Director of Product Development Chad Renshaw. “The PDR is among the most substantiated resources in the medical community and is distributed to 500,000 health professionals across the United States. Having 4Life products included provides distributors with unrivaled credibility when presenting our products to customers.”

The 2013 edition of the PDR provides in-depth product information about 4Life Transfer Factor® and 4Life® Transfer Factor Plus® Tri-Factor® Formulas. In addition, the publication offers a technical description of the product line and synopses on several scientific studies.

With nine worldwide patents and dozens more pending, an in-house Research and Development team, the scientific input of the Health Sciences Advisory Board, and the industry’s only immunological testing lab, 4Life’s commitment to Transfer Factor science is well established.

Director of Health Information Systems Brent Vaughan: “This professional listing is an invaluable asset for 4Life distributors. The publication strengthens the field’s position as exclusive leaders in the distribution of 4Life Transfer Factor products.”

4Life has offices on five continents to serve a global network of independent distributors through science, success, and service.

4Life Transfer Factor® Products Approved for Use by Olympic Athletes

Salt Lake City, Utah (December 4, 2007) As first reported by 4Life Chief Scientific Officer Calvin McCausland, Ph.D., in Direct Selling News, 4Life received documentation from the Federal Anti-Doping Center in Moscow, Russia, that admits 4Life Transfer Factor for use by Olympians in practice, training, and competition. Approval was obtained after volunteers consumed 4Life Transfer Factor products and their bodily fluids were analyzed in accordance with doping control procedures that employ modern methods of gas chromatography and mass-spectrometry in compliance with the World Anti-Doping Agency in Montreal, Canada.

“We are very pleased by this approval,” commented President of Eurasia Emma Oganova, M.D., Ph.D. “4Life Transfer Factor continues to define the cutting-edge of immune system science.”

4Life Founder and Chief Executive Officer David Lisonbee launched 4Life Research in 1998 with a commitment to the highest scientific standards. Ongoing research and development of Transfer Factor technology has fueled 4Life’s constant growth and maximized every distributor’s ability to grow a successful independent business.

“Arguably, this kind of marketplace positioning and high level product messaging simply isn’t possible without the involvement of a professional research and development team,” added McCausland.

“I am pleased with our continued evolution in the supplement industry,” stated Executive Vice President Bruce Redd. “The quality work of our Research and Development department is certain to keep 4Life on the leading edge of science and success for years to come.”

4Life, the leader in the development, production, and distribution of Transfer Factor support products, continues to post growth in more than 40 countries around the world.

4Life Research Announces New Discovery

September 21, 2007 (Salt Lake City, Utah) 4Life Research™, the world leader in Transfer Factor science and immune system support development, announced today the discovery of immune activity in a weight range of molecules significantly smaller than transfer factors.

Transfer factors are molecules in a weight class between 3,500 - 12,000 daltons that help the immune system recognize, respond to, and remember outside threats. Although scientists have known that smaller molecules than transfer factors existed within cow colostrum, their significance in terms of immune activity has been unknown until now.

In 2005, 4Life Chief Executive Officer David Lisonbee and the Research and Development department began studying these low weight molecules. After two years of research, 4Life clinical findings now indicate that molecules in a weight range between 250 — 3,000 daltons play important regulatory roles in the immune system.

4Life extracted and concentrated these nanofraction molecules from cow colostrum for their proprietary NanoFactor™ extract, combining NanoFactor with their exclusive Transfer Factor E-XF™ extract of transfer factors from cow colostrum and chicken egg yolks to produce 4Life Transfer Factor® Tri-Factor™ Formula, the most comprehensive approach to immune system support available today.

"I don't know of another company in our category," said 4Life Chief Scientific Officer Calvin McCausland, Ph.D. "In 2004, we were the first company to combine transfer factors from cow colostrum and chicken egg yolks. In 2005, we introduced RioVida®, the world's only transfer factor beverage. Now, the discovery of new immune activity in nanofractions. When it comes to scientific innovation, there's simply no comparison to 4Life."

4Life Transfer Factor, Transfer Factor Plus®, and RioVida are now fortified with the new Tri-Factor Formula. "We're taking Tri-Factor Formula to the world because no other product represents such a unique and indispensable opportunity for a quality life," remarked 4Life President Steve Tew.

David Lisonbee: "At the end of the day, our distributors can rest assured that 4Life will stay a good pace ahead of the curve in the areas of science, service, and success."

4Life, global leader in the development, production, and distribution of Transfer Factor immune support products, continues to post growth in more than 40 countries around the world.

4Life^® Transfer Factor™ Now Approved By the Health Ministry of Russia for use in Hospitals and Clinics!

First Ever Dietary Supplement to be Approved for Use by Doctors and Hospitals in Russia

SANDY, UT (October 1, 2004) - In an unprecedented announcement in the history of network marketing, 4Life announced today that 4Life Transfer Factor products as immune modulators have been approved for use in hospitals and clinics in the Russian Federation. The results of ten separate clinical trials and two experimental studies on 4Life Transfer Factor products were combined in a Methodological Document that was approved by the Ministry of Health, which now allows doctors to recommend 4Life Transfer Factor Classic and 4Life Transfer Factor Plus® products to their patients.

First Dietary Supplement Approved for Use by Doctors and Hospitals in Russia

Commenting on this remarkable achievement, David Lisonbee, CEO of 4Life stated, “To my knowledge, this is the first time in the history of this industry that a network marketing company or any other dietary supplement company has had one of its dietary supplements approved for use in hospitals in Russia. The Russian Ministry of Health is the equivalent of the Food and Drug Administration in the United States. Doctors and scientists from Russia have been working jointly with scientists from 4Life for several years to arrive at this accomplishment. This approval establishes a new roll of dietary supplements in the Russian health care system.

Remarkable Response from Russian Academy of Medical Sciences

In another sector of research of 4Life Transfer Factor, Dr. Kisielevsky of the Russian Academy of Medical Sciences stated, “The 4Life sample [Transfer Factor Advanced Formula] activated NK (natural killer) cell activity more than the Interleukin-2 (IL2) drug we used as the standard.” This discovery has attracted the attention of The International Scientific and Technical Center (ISTC) of Russia.

Scientists from Several Countries Join Forces for Additional Clinical Studies of Transfer Factor

The ISTC of Russia is a member of a joint international project with other health agencies of Japan, Europe and the US. The objective of the international project is to combine efforts in finding improved immunotherapies. Following the discoveries from the NK cell testing, the scientists of 4Life have been invited to join the project. 4Life Transfer Factor as an immune modulator will be further researched in this international forum. The cost of the studies will be paid by the ISTC.

Worldwide Ramification

Speaking of this benchmark achievement, Dr. Calvin McCausland, VP of Research of 4Life, and Dr. Emma Oganova, 4Life/Eurasia President, jointly expressed that because of the acceptance by such a reputable organization and doctors from Russia and other major countries, 4Life Transfer Factor will gain wider acceptance in the professional and private sectors as a superior immune system enhancing product. The worldwide ramifications to this acceptance are just beginning.

4Life Research is the World’s foremost leader in the development, production and distribution of natural immune support products and was recently recognized by Inc. magazine as the fifteenth fastest growing privately-held company in America.